BamSEC and AlphaSense Join Forces
Learn More

Bioxytran Inc

OTC: BIXT    
Share price (1/7/25): $0.08    
Market cap (1/7/25): $6.863 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.86
from 8-K 3 pages Extract From Valuation Report
12/34/56
EX-10.85
from 8-K 2 pages Stock Sale and Purchase Agreement
12/34/56
EX-10.84
from 8-K 3 pages Confidential Term Sheet July 15, 2024
12/34/56
EX-10.83
from 10-Q 4 pages Bioxytran, Inc Stock Option
12/34/56
EX-10.82
from 10-K 4 pages Security Purchase Agreement
12/34/56
EX-10.81
from 10-K 6 pages Bioxytran, Inc. Convertible Note
12/34/56
EX-10.80
from 10-Q 6 pages Common Stock Purchase Option Pharmalectin, Inc
12/34/56
EX-10.79
from S-1 4 pages Closing Agreement
12/34/56
EX-10.78
from S-1 6 pages Debt Modification Agreement
12/34/56
EX-10.77
from S-1/A 4 pages Amended Closing Agreement
12/34/56
EX-10.76
from 8-K 5 pages Closing Agreement
12/34/56
EX-10.75
from 8-K 1 page Amendment to Engagement Letter
12/34/56
EX-10.74
from 10-Q 10 pages The Offering
12/34/56
EX-10.73
from 10-Q 40 pages Confidential Private Placement Memorandum Bioxytran, Inc. Price to Subscribers Commissions (1) Fees (2) Proceeds to Company Maximum Offering $ 3,000,000 — — $ 3,000,000
12/34/56
EX-10.56
from 8-K ~5 pages Amendment to Employment Agreement
12/34/56
EX-10.72
from 8-K 9 pages The Offering
12/34/56
EX-10.71
from 8-K 1 page Official Uspto Notice of Publication Under 12(a) U.S. Application Serial No. 90888912 Mark: Prolectin International Class(es): 005 Owner: Pharmalectin, Inc. Docket/Reference No. 51577-T02001 Issue Date: June 8, 2022 Your Mark Is Scheduled to Publish in the Trademark Official Gazette (Tmog) on June 28, 2022
12/34/56
EX-10.70
from 8-K 1 page Approval of International Patent Wo2022/099061 - Polysaccharides for IV Administration That Treat Sars-Cov-2 Infections, Dated May 12, 2022
12/34/56
EX-10.69
from 8-K 1 page Approval of International Patent Wo2022/099052 - Polysaccharides for Use in Treating Sars-Cov-2 Infections, Dated May 12, 2022
12/34/56
EX-10.68
from 8-K 7 pages Note Purchase Agreement
12/34/56